Although there have been no studies assessing NRAS as a synthetic dose lethal target in melanoma, in acute myeloid leukaemia (AML) the multitarget kinase inhibitor GNF‐7 has been reported to induce apoptosis in NRAS‐mutant but not wild‐type AML. This evidence concerns the gene NRAS and acute myeloid leukemia.